Methods of treatment with bispecific antibodies binding to beta-klotho and fibroblast growth factor receptor 1
US9884919B2 · kind B2 · utility
0Cited by
19References
16Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 19, 2016 |
| Grant date | Feb 6, 2018 |
| Priority date | — |
| Expiry date | Jul 19, 2036 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The presently disclosed subject matter provides antibodies that bind KLB and FGFR1, and methods of using the same. In certain embodiments, an antibody of the present disclosure includes a bispecific antibody that binds to an epitope present on FGFR1 and binds to an epitope present on KLB.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.